A detailed history of Vestor Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Vestor Capital, LLC holds 75,004 shares of ABT stock, worth $8.54 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
75,004
Previous 77,231 2.88%
Holding current value
$8.54 Million
Previous $8.78 Million 11.21%
% of portfolio
0.63%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$100.73 - $112.44 $224,325 - $250,403
-2,227 Reduced 2.88%
75,004 $7.79 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $143,690 - $158,699
-1,312 Reduced 1.67%
77,231 $8.78 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $24,531 - $30,028
272 Added 0.35%
78,543 $8.65 Million
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $96,198 - $115,422
-1,007 Reduced 1.27%
78,271 $7.58 Million
Q2 2023

Aug 21, 2023

SELL
$100.78 - $112.29 $10.2 Million - $11.4 Million
-101,657 Reduced 56.18%
79,278 $8.64 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $10.1 Million - $11.3 Million
100,588 Added 125.19%
180,935 $61.6 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $5.8 Million - $6.82 Million
-59,851 Reduced 42.69%
80,347 $8.14 Million
Q1 2023

Apr 26, 2023

BUY
$96.86 - $114.01 $5.63 Million - $6.63 Million
58,137 Added 70.85%
140,198 $40.4 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $410,183 - $481,208
-4,315 Reduced 5.0%
82,061 $9.01 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $5.71 Million - $6.61 Million
-59,034 Reduced 40.6%
86,376 $8.36 Million
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $196,076 - $236,993
1,921 Added 1.34%
145,410 $15.8 Million
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $48,572 - $59,231
-426 Reduced 0.3%
143,489 $17 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $2.99 Million - $3.66 Million
-25,875 Reduced 15.24%
143,915 $20.3 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $1,516 - $1,677
-13 Reduced 0.01%
169,790 $20.1 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $3.08 Million - $3.62 Million
-29,109 Reduced 14.63%
169,803 $19.7 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $631,489 - $743,990
5,802 Added 3.0%
198,912 $23.8 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.74 Million - $1.9 Million
-16,587 Reduced 7.91%
193,110 $21.1 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $1.51 Million - $1.84 Million
16,530 Added 8.56%
209,697 $22.8 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $33,734 - $49,328
537 Added 0.28%
193,167 $15.2 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $580,816 - $646,585
7,398 Added 3.99%
192,630 $16.7 Million
Q3 2019

Nov 20, 2019

BUY
$81.84 - $88.74 $523,448 - $567,581
6,396 Added 3.58%
185,232 $15.5 Million
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $209,165 - $243,950
2,870 Added 1.63%
178,836 $15 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $4.72 Million - $5.7 Million
-71,246 Reduced 28.82%
175,966 $14.1 Million
Q4 2018

Feb 15, 2019

BUY
$65.56 - $74.27 $2.36 Million - $2.67 Million
35,968 Added 17.03%
247,212 $17.9 Million
Q3 2018

Nov 19, 2018

SELL
$60.81 - $73.36 $493,473 - $595,316
-8,115 Reduced 3.7%
211,244 $15.5 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $70,753 - $78,090
-1,229 Reduced 0.56%
219,359 $13.4 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $988,607 - $1.12 Million
17,569 Added 8.65%
220,588 $13.2 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $534,706 - $572,458
9,961 Added 5.16%
203,019 $11.6 Million
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $9.28 Million - $10.4 Million
193,058
193,058 $10.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vestor Capital, LLC Portfolio

Follow Vestor Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.